Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;

> Phase III data show polycythemia vera patients on Novartis' ($NVS) Jakavi achieved significant improvement in disease control. Release

> Johnson & Johnson ($JNJ) has shifted its U.S. media buying account to OMD, part of the Omnicom Media Group division of the Omnicom Group. More (sub. req.)

> AbbVie ($ABBV), Astellas and Roche ($RHHBY) have been nominated for the Pegasus Award for In-House Team of the Year at Communiqué. More

> Brand experience agency SSG Create has secured Botox-maker Allergan ($AGN) as a client. Report

> IDEA Pharma has appointed UPenn research specialist Rick Ritacco to its New York practice. Release

> Jack Morton Worldwide has opened an office in Düsseldorf, Germany, following client wins with Novartis ($NVS) and Merck Serono. More

> Johnson & Johnson ($JNJ), a World Cup sponsor through its Listerine and Regaine brands, has helped fuel growth at sponsorship agency Prism. More

And Finally... EpiPen maker Mylan ($MYL) and NFL star Adrian Peterson are calling on Americans to learn to be aware and prepared for anaphylaxis. Release

Suggested Articles

Only months removed from a gamechanging label expansion for Vascepa, Amarin is scrambling after a district judge invalidated the drug's key patents.

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.